Eikon Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -5,113 | -5,105 |
EBITDA | -77,845 | -74,550 |
EBIT | -82,958 | -79,655 |
Net Income | -82,958 | -79,655 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -90,063 | -41,790 |
Cash | 161,554 | 104,901 |
Basic Shares | 54,138 | 54,138 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -24,176 | ||
EBITDA | -299,235 | ||
EBIT | -323,411 | ||
Net Income | -324,248 | -243,814 | -241,997 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -235,257 | -219,602 | -219,361 |
Cash | 104,901 | 129,179 | 112,784 |
Basic Shares | 54,138 | 53,984 | 53,984 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.63 |
2026-03-31 | -$2.46 |
2025-12-31 | -$26.23 |